Related references
Note: Only part of the references are listed.Comparative effects of high-dose atorvastatin versus moderate-dose rosuvastatin on lipid parameters, oxidized-LDL and inflammatory markers in ST elevation myocardial infarction
Meryem Ulku Aydin et al.
ATHEROSCLEROSIS (2015)
Risk identification and possible countermeasures for muscle adverse effects during statin therapy
Paolo Magni et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2015)
Efficacy and Safety of Alirocumab in Reducing Lipids and Cardiovascular Events
Jennifer G. Robinson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Efficacy and Safety of Evolocumab in Reducing Lipids and Cardiovascular Events
Marc S. Sabatine et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Possible association of ABCB1:c.3435T>C polymorphism with high-density-lipoprotein-cholesterol response to statin treatment - a pilot study.
Anna Sałacka et al.
Bosnian Journal of Basic Medical Sciences (2015)
Evaluating cardiovascular event reduction with ezetimibe as an adjunct to simvastatin in 18,144 patients after acute coronary syndromes: Final baseline characteristics of the IMPROVE-IT study population
Michael A. Blazing et al.
AMERICAN HEART JOURNAL (2014)
Inflammatory Stress Induces Statin Resistance by Disrupting 3-Hydroxy-3-Methylglutaryl-CoA Reductase Feedback Regulation
Yaxi Chen et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2014)
Association between statin-induced creatine kinase elevation and genetic polymorphisms in SLCO1B1, ABCB1 and ABCG2
Marco Ferrari et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2014)
The role of common variants of ABCB1 and CYP7A1 genes in serum Lipid levels and Lipid-Lowering efficacy of statin treatment: A meta-analysis
Qing Li et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2014)
Lipid lowering with PCSK9 inhibitors
Razvan T. Dadu et al.
NATURE REVIEWS CARDIOLOGY (2014)
Resistance and intolerance to statins
Z. Reiner
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2014)
Do MDR1 and SLCO1B1 Polymorphisms Influence the Therapeutic Response to Atorvastatin? A Study on a Cohort of Egyptian Patients with Hypercholesterolemia
Mona F. Shabana et al.
MOLECULAR DIAGNOSIS & THERAPY (2013)
Identification of pharmacogenetic predictors of lipid-lowering response to atorvastatin in Chilean subjects with hypercholesterolemia
Alexy Rosales et al.
CLINICA CHIMICA ACTA (2012)
ABCB1 C3435T Polymorphism and Response to Clopidogrel Treatment in Coronary Artery Disease (CAD) Patients: A Meta-Analysis
Jia Su et al.
PLOS ONE (2012)
Individualized risk for statin-induced myopathy: current knowledge, emerging challenges and potential solutions
QiPing Feng et al.
PHARMACOGENOMICS (2012)
The C3435T polymorphism in ABCB1 influences atorvastatin efficacy and muscle symptoms in a high-risk vascular cohort
Michel R. Hoenig et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2011)
Combined therapy in the treatment of dyslipidemia
Zeljko Reiner
FUNDAMENTAL & CLINICAL PHARMACOLOGY (2010)
Narrative Review: Statin-Related Myopathy
Tisha R. Joy et al.
ANNALS OF INTERNAL MEDICINE (2009)
ABCB1 and ABCC1 expression in peripheral mononuclear cells is influenced by gene polymorphisms and atorvastatin treatment
Ivanise Marina Moretti Rebecchi et al.
BIOCHEMICAL PHARMACOLOGY (2009)
Association of ABCB1 gene polymorphisms with plasma lipid and apolipoprotein concentrations in the STANISLAS cohort
Elise Jeannesson et al.
CLINICA CHIMICA ACTA (2009)
Lipid management in the prevention of stroke: review and updated meta-analysis of statins for stroke prevention
Pierre Amarenco et al.
LANCET NEUROLOGY (2009)
Influence of pravastatin on carotid artery structure and function in dyslipidemic HIV-infected patients receiving antiretroviral therapy
Franck Boccara et al.
AIDS (2006)
Phenotypic predictors of response to Simvastatin therapy among African-Americans and Caucasians:: The Cholesterol and Pharmaeogenetics (CAP) Study
JA Simon et al.
AMERICAN JOURNAL OF CARDIOLOGY (2006)
The association of common SNPs and haplotypes in the CETP and MDRI genes with lipids response to fluvastatin in familial hypercholesterolemia
D Bercovich et al.
ATHEROSCLEROSIS (2006)
The role of common variants of ABCB1, CYP3A4, and CYP3A5 genes in lipid-lowering efficacy and safety of simvastatin treatment
M Fiegenbaum et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2005)
High baseline serum total and LDL cholesterol levels are associated with MDR1 haplotypes in Brazilian hypercholesterolemic individuals of European descent
AC Rodrigues et al.
BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH (2005)
Reduction in cardiovascular events with atorvastatin in 2,532 patients with type 2 diabetes:: Anglo-Scandinavian Cardiac Outcomes Trial-Lipid-Lowering Arm (ASCOT-LLA)
PS Sever et al.
DIABETES CARE (2005)
Turpentine-induced inflammation reduces the hepatic expression of the multiple drug resistance gene, the plasma cholesterol concentration and the development of atherosclerosis in apolipoprotein E deficient mice
M Tous et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2005)
Polymorphisms in the multidrug resistance-1 (MDR1) gene influence the response to atorvastatin treatment in a gender-specific manner
K Kajinami et al.
AMERICAN JOURNAL OF CARDIOLOGY (2004)
Current overview of statin-induced myopathy
RS Rosenson
AMERICAN JOURNAL OF MEDICINE (2004)
Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study
S Yusuf et al.
LANCET (2004)
Measuring inconsistency in meta-analyses
JPT Higgins et al.
BMJ-BRITISH MEDICAL JOURNAL (2003)
Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid Lowering Arm (ASCOT-LLA):: a multicentre randomised controlled trial
PS Sever et al.
LANCET (2003)
Statin-associated myopathy
PD Thompson et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
The multidrug transporter, P-glycoprotein, actively mediates cholesterol redistribution in the cell membrane
A Garrigues et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Empirical assessment of effect of publication bias on meta-analyses
AJ Sutton et al.
BMJ-BRITISH MEDICAL JOURNAL (2000)
Role of P-glycoprotein in drug disposition
Y Tanigawara
THERAPEUTIC DRUG MONITORING (2000)
Share Paper
